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Abstract Acidic glycosphingolipid components were extracted
from the yeast form of the dimorphic mycopathogen Sporothrix
schenckii. Two minor and the major fraction from the yeast form
(Ss-Y1, -Y2, and -Y6, respectively) have been isolated. By a
combination of 1- and 2-D 1H-nuclear magnetic resonance
(NMR) spectroscopy, electrospray ionization mass spectrometry
(ESI-MS), and gas chromatography/mass spectrometry
(GC/MS), Ss-Y6 was determined to be triglycosylinositol
phosphorylceramide with a novel glycan structure, ManK1C
3ManK1C6GlcNH2K1C2Ins1-P-1Cer (where Ins = myo-ino-
sitol, P = phosphodiester). While the GlcNH2K1C6Ins1-P-
motif is found widely distributed in eukaryotic GPI anchors,
the linkage GlcNH2K1C2Ins1-P- has not been previously
observed in any glycolipid. Ss-Y1 and Ss-Y2 were both found
to have the known glycan structure ManK1C3ManK1C2Ins1-
P-1Cer. Together with the results of a prior study [Toledo et al.
(2001) Biochem. Biophys. Res. Commun. 280, 19^24] which
showed that the mycelium form expresses GIPCs with
the structures ManK1C6Ins1-P-1Cer and ManK1C3ManK1
C6Ins1-P-1Cer, these results demonstrate that S. schenckii can
synthesize glycosylinositol phosphorylceramides with at least
three different core linkages. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The risk of systemic fungal disease among growing popu-
lations of immunosuppressed or -compromised patients [5],
along with recent work showing that fungi are vulnerable to
inhibitors of sphingolipid biosynthesis (reviewed in [6]), has
led to an increased interest in the structure, biosynthesis, and
functional roles of fungal sphingolipids as potential targets for
antifungal agents. A particularly interesting target is the fun-
gal inositol phosphorylceramide (IPC) synthase [6], inhibitors
of which are highly toxic to many mycopathogens, but exhibit
low toxicity in mammals [7^10]. IPC synthase catalyzes the
transfer of myo-inositol-1-phosphate from phosphatidylinosi-
tol to ceramide; further processing of IPC by glycosyltrans-
ferases yields glycosylinositol phosphorylceramides (GIPCs).
A number of studies have pointed to potential interactions
of GIPCs of fungi with the mammalian immune system [11^
13]. Elucidation of such interactions calls for detailed knowl-
edge of the structures of these compounds, which is still lim-
ited in comparison to what is known about glycosphingolipids
(GSLs) of animal species. Also, as occurred earlier with mam-
malian studies, expanding knowledge of fungal GIPC struc-
tures can be expected, by extension, to reveal a great deal
about the activities and expression patterns of the enzymes
responsible for their synthesis. The detection of novel glycosyl
linkages, and therefore of novel glycosyltransferases, is an
important complement to molecular and cell biological ap-
proaches to glycoconjugate function; in addition, speci¢c
GIPC processing enzymes could o¡er further potential targets
for development of inhibitors as antifungal agents.
In this paper, we report on the structure elucidation of
GIPCs from the dimorphic mycopathogen Sporothrix
schenckii. Among other observations, these studies revealed
that a major component of the yeast form has the structure
ManK1C3ManK1C6GlcNH2K1C2Ins1-P-1Cer2. To our
knowledge, this is the ¢rst report of any glycolipid with the
GlcNH2K1C2Ins1-P- structural motif, although the isomeric
GlcNH2K1C6Ins1-P- linkage is commonly encountered in
eukaryotic GPI anchored proteins and phosphoglycans
[14,15].
2. Materials and methods
2.1. Fungal isolate and growth conditions
The culture of S. schenckii, strain 65 (originally obtained from
cutaneous footpad lesion of an otherwise healthy individual), was
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provided by Dr. Olga Gompertz, Department of Cellular Biology,
Universidade Federal de Sa‹o Paulo/Escola Paulista de Medicina,
Sa‹o Paulo, SP, Brazil. Mycelium and yeast forms of S. schenckii strain
65 were grown in brain-heart infusion (BHI; 37 g/l water), incubated
at 25 and 37‡C, respectively, and harvested as described [16].
2.2. Extraction, puri¢cation, and thin layer chromatographic analysis of
GSLs
Extraction and puri¢cation of GSLs were carried out as described
previously [11,17,18]. Brie£y, GPls were extracted by homogenizing
yeast or mycelium forms (25^35 g wet weight) in an Omni-mixer
(Sorvall Inc. Wilmington, DE, USA), three times with 200 ml of
isopropanol/hexane/water (55:20:25, v/v/v, upper phase discarded),
and twice with 200 ml of chloroform/methanol (2:1, v/v). The ¢ve
extracts were pooled, dried on a rotary evaporator, dialyzed against
water, lyophilized, resuspended in chloroform/methanol/water
(30:60:8, v/v/v; solvent A), and applied to a column of DEAE-Sepha-
dex A-25 (Ac3 form). Neutral GSLs were eluted with ¢ve volumes of
solvent A. Acidic GSLs were eluted with ¢ve volumes of 0.5 M so-
dium acetate in MeOH. The acidic fraction was dried, dialyzed ex-
haustively against deionized water, redried and further puri¢ed by
repetitive preparative-scale high performance liquid chromatography
(HPLC) (50 cmU4.6 mm Sphereclone (Phenomenex, Torrance, CA,
USA) 10 Wm porous spherical silica; elution with 2-propanol-hexane-
water gradient from 55:40:5 to 55:25:20 over 120 min, then isocratic
for 40 min; £ow rate 0.5 ml/min; 80U1 ml fractions collected). The
identity and purity of each fraction was assessed by analytical high
performance thin layer chromatography (HPTLC), performed on sili-
ca gel 60 plates (E. Merck, Darmstadt, Germany) using chloroform/
methanol/water (60:35:10, v/v/v) as mobile phase, with detection by
Bial’s orcinol reagent.
2.3. 1H-Nuclear magnetic resonance (NMR) spectroscopy
Samples of underivatized GIPC (V0.5^1.0 mg) were deuterium
exchanged by repeated evaporation from CDCl3/CD3OD (2:1, v/v)
under N2 stream at 37‡C, and then dissolved in 0.5 ml dimethyl
sulfoxide (DMSO)-d6/2% D2O [19] for NMR analysis. 1-D 1H-
NMR, 2-D 1H^1H-gradient correlation spectroscopy (COSY) [20],
-total correlation spectroscopy (TOCSY) [21,22] and -nuclear Over-
hauser e¡ect spectroscopy (NOESY) [23] experiments were performed
at 35‡C on Varian Unity Inova 600 or 800 MHz spectrometers using
standard acquisition software available in the Varian VNMR software
package. Proton chemical shifts are referenced to internal tetramethyl-
silane (N= 0.000 ppm).
2.4. Electrospray ionization mass spectrometry (ESI-MS)
ESI-MS and tandem ESI-MS/collision-induced decomposition
(CID)-MS were performed in the positive ion mode with Li adduc-
tion on a PE-Sciex (Concord, ON, Canada) API-III spectrometer,
using a standard Ionspray source (ori¢ce-to-skimmer voltage (OR),
100^130 V or 160^180 V (‘high OR’); Ionspray voltage, 5 kV; inter-
face temperature, 45‡C) and sample introduction by direct infusion
(3^5 Wl/min) of GIPC samples dissolved (V20 ng/Wl) in 100% MeOH.
For generation of Li adducts, a solution of LiI (10 mM) in MeOH
was added [4,24] until the observed ratio of MWLi2 to MWLiNa
 in
ESI-MS pro¢le mode was s 95:5 (the ¢nal concentration of LiI was
generally 3^6 mM). For ESI-MS/CID-MS experiments, precursor
ions selected in Q1 were subjected to collision induced dissociation
(with argon as collision gas) in Q2, while the useful mass range (start-
ing from m/z 100) was scanned in Q3 (0.2 u steps); alternatively,
appropriate product ions were selected in Q3 while the useful precur-
sor mass range was scanned in Q1. OR was set to 100^120 V; other
parameters were as described previously [24]. In general, spectra rep-
resent summations of 10^30 scans for single analyzer pro¢les, and 30^
50 scans for CID experiments. Fragment nomenclature is after Do-
mon and Costello [25,26] as modi¢ed for use with GIPCs [27]. Nom-
inal monoisotopic m/z values are used in the description of all ESI-MS
results.
2.5. Miscellaneous procedures
Selective N-acetylation was carried out on an aliquot of Ss-Y6: to
V200 Wg in 1 ml MeOH was added 50 Wl pyridine and 50 Wl acetic
anhydride; vortexed and incubated for 1 h at room temperature;
evaporated to dryness (three times with addition of toluene) under
N2 stream at 37‡C. Component analyses were performed by gas chro-
matography (GC)/MS of per-O-trimethylsilyl (TMS) derivatives of
methyl glycosides, inositol, sphingoids, and fatty acid methyl ester
(FAME)s released from GIPCs by methanolysis, using procedures
described in detail elsewhere [3].
3. Results
3.1. HPTLC pro¢le of S. schenckii GIPCs
HPTLC pro¢les of GIPCs from mycelial and yeast forms of
S. schenckii di¡ered considerably, as shown in Fig. 1. In the
mycelial form, ¢ve bands were visible with orcinol staining,
designated Ss-M1 through Ss-M5 (lane M). Of these, the ¢rst
three appeared to be major components, with decreasing
amounts of Ss-M4 and Ss-M5. Characterization of Ss-M1,
-M2, and -M3 has been reported [4]. The appearance of
GIPCs from the yeast form was more complex, with ¢ve
very minor bands, designated Ss-Y1 through Ss-Y5, migrating
above a single major band, Ss-Y6, having a very low Rf (lane
Y). Several more closely spaced minor band were visible be-
low this one. Of these yeast form fractions, only Ss-Y1, -Y2,
and -Y6 were puri¢ed in su⁄cient quantity and were homo-
geneous enough for detailed characterization.
3.2. Characterization of S. schenckii yeast form GIPCs
(Ss-Y1, -Y2, and -Y6)
1-D 1H-NMR spectra of S. schenckii yeast form fractions
Ss-Y1 and Ss-Y2 (not shown) were both essentially identical
to that of ManK3ManK2IPC previously isolated and charac-
terized from Paracoccidoides brasiliensis [3]. At least with re-
spect to glycan structure, the identities of Ss-Y1 and -Y2 were
therefore considered to be known.
Fig. 1. HPTLC analysis comparing crude S. schenckii mycelium and
yeast form GIPC fractions (Lanes M and Y, respectively). Top half
of plate has been cropped; original image contrast-enhanced using
software available with Corel Photopaint 8.0. Orcinol positive com-
ponents are numbered as shown to left and right of lanes (Ss-M1
through -M5 and Ss-Y1 through -Y8, respectively). The asterisk-ar-
row (6*) marks the position of migration on this plate of authen-
tic ManK3ManK2InsPCer from P. brasiliensis.
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Component analysis by GC/MS indicated that fraction Ss-
Y6 contained mannose, glucosamine (detected as GlcNAc),
and myo-inositol in ratio 2:1:1; other components detected
were t18:0 and t20:0 4-hydroxysphinganines (phytosphingo-
sines) and h24:0 fatty acid (major). The relevant down¢eld
section of a 1-D 1H-NMR spectrum of fraction Ss-Y6 is re-
produced in Fig. 2; a section of the TOCSY spectrum corre-
sponding to this region is reproduced in Fig. 3A. Chemical
shift/connectivity assignments of all 1H signals, as well as
approximate measurements of 3Ji;j coupling constants, in the
monosaccharide, inositol, and proximal part of the ceramide
were obtained from sequential application of 2-D 1H^1H gra-
dient-COSY and TOCSY experiments. Complete assignments
of 1H resonances derived from this analysis are listed in Table
1. The myo-inositol residue was recognized as a cyclic spin
system in which all 3Ji;j are large except for 3J1;2 and 3J2;3,
as H-2 is the only equatorial proton in the 1,2,3,4,5,6-hexahy-
droxy-cyclohexane ring. The three monosaccharide residues
were recognized by their connectivity/coupling patterns [28]
starting from the most down¢eld signal (H-1) of each spin
system. Aside from the presence of two Man residues recog-
nizable by their signature small values for 3J1;2 and 3J2;3, the
NMR spectrum of Ss-Y6 is characterized in particular as ex-
hibiting a sugar H-2 signal shifted far up¢eld at 2.380 ppm,
part of a spin system, originating from H-1 at 5.011 ppm,
having 3Ji;j coupling patterns consistent with an K-glucopyr-
anosyl con¢guration. The up¢eld shifted signal is consistent
with H-2 attached to a carbon atom bearing a free amino
group. The linkage assignments were established by observa-
tion in the NOESY spectrum (Fig. 3B) of strong interresidue
correlations between H-1 of the GlcNH2 residue and Ins H-2
(3.982 ppm), between Man H-1 at 4.623 ppm and GlcNH2 H-
6 (3.568 ppm), and between Man H-1 at 4.885 ppm and H-3
of the ¢rst Man residue (3.614 ppm). Weak interresidue cor-
Fig. 2. Down¢eld sections of 1-D 1H-NMR spectra of GIPC fractions Ss-Y6 (A) and Ss-M3 (B). Key reporter signals are labeled.
Fig. 3. Sections of 2-D 1H-NMR spectra of GIPC fraction Ss-Y6; 1H^1H-TOCSY (A) and 1H^1H-NOESY (B). Key through-bond chemical
shift correlations for the myo-inositol and three monosaccharide residues are labeled in A, key interresidue NOE correlations are boxed and la-
beled in B.
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relations were also observed from Man H-1 to GlcNH2 H-5
(4.046 ppm) and other H-6 (3.645 ppm). Based on NMR
spectroscopic analysis, the structure of Ss-Y6 could be pro-
posed as ManK3ManK6GlcNH2K2IPC.
In ESI-MS analysis two major MWLi2 for Ss-Y6 were ob-
served at m/z 1423 and 1451, in Vequal abundance (Fig. 4A),
consistent with a composition of Hex2WHexNH2WInsWP linked
to Cers composed of t18:0 and t20:0 phytosphingosines with
h24:0 fatty acid. Some minor ceramide variants di¡ering by
14 Th (CH2) increments from the major species were also
detectable. Product ion mode ESI-MS/CID-MS of the
molecular species at both m/z 1423 and 1451 (data not
shown; designations of fragments are illustrated in Scheme
1) yielded signi¢cant fragments at m/z 255 [InsWPWLi2] ([Y1/
B4PO3WLi2]), 331 [B2WLi], 416 [HexNH2WInsWPWLi2] ([Y2/
B4PO3WLi2]), 434 [HexNH2WInsWPWLi2] ([Y2/C4PO3WLi2]),
492 [B3WLi] or [Y3/B4WLi], 510 [C3WLi] or [Y3/C4WLi],
578 [HexWHexNH2WInsWPWLi2] ([Y3/B4PO3WLi2]), 596
[HexWHexNH2WInsWPWLi2] ([Y3/C4PO3WLi2]), 654 [B4WLi],
672 [C4WLi], 740 [Hex2WHexNH2WInsWPWLi2] ([B4PO3WLi2]),
and 758 [Hex2WHexNH2WInsWPWLi2] ([C4PO3WLi2]). Ceram-
ide-related ions were observed at m/z 690 [CerWLi]
([Y0WLi]) and 776 [CerPO3WLi2] ([Y0PO3WLi2]) in the prod-
uct spectrum from m/z 1423. In the product spectrum from
m/z 1451, these were shifted to m/z 718 and 802, respectively.
The identity and placement of the HexNH2 residue in the
sequence was con¢rmed by treating an aliquot of Ss-Y6 with
acetic anhydride under conditions known to yield selective N-
acetylation. Following this treatment, the two major molecu-
lar ion species were observed in ESI-MS pro¢le at m/z 1465
and 1493, respectively (Fig. 4B), consistent with addition of
one acetyl group, i.e. conversion of the HexNH2 residue to
HexNAc. Although the high OR ESI-MS spectrum was too
noisy to interpret fully, fragments were clearly observable at
m/z 255 [InsWPWLi2] ([Y1/B4PO3WLi2]), 690 and 718 [CerWLi]
([Y0WLi]), and 800 [Hex2WHexNAcWInsWPWLi2] ([C4PO3WLi2])
(data not shown). ESI-MS/CID-MS precursor ion scanning
from the m/z 800 fragment (Fig. 5A) clearly showed its origins
from the major molecular ions at m/z 1465 and 1493; minor
molecular species at m/z 1479, 1507, and 1521 were also de-
tectable (V5^10% the abundance of m/z 1493). ESI-MS/
CID-MS product ion scanning from the m/z 800 fragment
(Fig. 5B) yielded abundant fragments characteristic for the
glycan sequence, i.e. at m/z 111 [H2PO4WLi2], 169 [B1WLi]
or [Y1/B4WLi], 187 [C1WLi] or [Y1/C4WLi], 255 [InsWPWLi2]
([Y1/B4PO3WLi2]), 273 [InsWPWLi2] [Y1/C4PO3WLi2], 331
[B2WLi], 349 [C2WLi], 372 [Y2/B4WLi], 390 [Y2/C4WLi],
398, 458 [HexNacWInsWPWLi2] ([Y2/B4PO3WLi2]), 476
[HexNacWInsWPWLi2] ([Y2/C4PO3WLi2]), 534 [B3WLi] or [Y3/
B4WLi], 552 [C3WLi] or [Y3/C4WLi], 696 [B4WLi], and 714
[C4WLi]. The pairs of fragments 331/349 (Hex2), 255/273
(InsWP), and 458/476 (HexNAcWInsWP) clearly exclude the Hex-
NAc residue from any other position in the sequence.
4. Discussion
Analysis of GIPCs in the dimorphic mycopathogen S.
schenckii (in [4] and the present study) has revealed (i) the
expression of a variety of glycan structures, some of which
have not been previously reported in fungi; (ii) di¡erent pat-
terns of both glycan and ceramide expression in the yeast
and mycelial forms of this fungus; and (iii) that, between
the two forms, S. schenckii is capable of creating at least three
di¡erent glycosyl linkages with the myo-inositol ring of
InsPCer. These are ManK1C2Ins, ManK1C6Ins, and
GlcNH2K1C2Ins; of these, the ¢rst has been con¢rmed to
be widely distributed in GIPCs of fungi [2,3,12,29]3, but the
second has been detected only recently in S. schenckii myce-
lium form GIPCs [4] ; the third linkage has not, to our knowl-
edge, been reported in any eukaryotic glycoconjugate or car-
bohydrate. The isomeric structure, GlcNH2K1C6Ins, is of
course well known as the common core linkage found in gly-
cosylinositol phospholipids (GIPLs) of parasites and in the
GPI protein membrane anchors widely distributed among eu-
karyotes [14,30]. The occurrence of non-N-acetylated glucos-
amine in another linkage to myo-inositol is particularly inter-
esting, since it is known from studies with mammalian and
trypanosomatid cells that two steps are required for formation
of GlcNH2K1C6Ins found in GPI anchors, transfer of
GlcNAc from UDP-GlcNAc to Ins of phosphatidylinositol,
and subsequent de-N-acetylation [30]. That both reactions
could occur together in forming an alternate glycosyl linkage
is an intriguing possibility.
From the results of this and other studies [2^4,12,29,31], a
picture is emerging of GIPC structural diversity which may
Scheme 1. Molecular ions and fragmentation of Ss-Y6 and N-acety-
lated Ss-Y6 in positive ion mode ESI-MS and -MS/CID-MS.
Table 1
1H chemical shifts (ppm) for monosaccharide, inositol, ceramide
sphingoid and fatty-N-acyl (in parentheses) residues of Man-
K3ManK6GlcNH2K2IPC (Ss-Y6) from S. schenckii in DMSO-d6/2%
D2O at 35‡C
Ss-Y6 ManK1C3ManK1C6GlcNH2K1C2Ins16PC1Cer
H-1 4.885 4.623 5.011 3.795 3.682, 4.024
(3J1;2) (6 2.0) (1.8) (3.6)
H-2 3.738 3.881 2.380 3.980 3.845 (3.838)
H-3 3.545 3.614 3.238 3.241 3.445
H-4 3.422 3.508 3.105 3.324 3.345
H-5 3.602 3.432 4.046 2.968
H-6 3.47 3.47 3.568 3.532
H-6P 3.63 3.63 3.645
3J1;2 (Hz) for monosaccharide residues are given in parentheses.
3 Although Barr et al. [2] did not specify precisely the linkage between
Man and Ins in their compounds, but characterized it as ManK1C
2/6Ins, NMR spectroscopy of H. capsulatum GIPCs shows that the
linkage is ManK1C2Ins1-P-1Cer as reported previously for GIPCs of
P. brasiliensis [3] and for Ss-Y1 and -Y2 as reported herein.
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ultimately rival that found in animal GSLs. As in the animal
kingdom, some structures appear to be shared in common by
two or more fungal species, while the overall expression rep-
ertoire may be unique for each species. A GIPC having the
structure ManK3(GalL4)ManK2IPC has been found in both
yeast and mycelium forms of Histoplasma capsulatum [2,12]3
and in the mycelium form of S. schenckii [4] ; and the common
intermediate structures ManK2IPC and ManK3ManK2IPC
have been isolated from several species [2,3,12,29]3. As with
their mammalian counterparts, patterns of GIPC expression
within a particular fungal species can also be expected to
depend in a complex manner on a variety of factors, such
as strain, culture conditions, and stage of development.
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Fig. 4. Singly charged Li adduct molecular ion pro¢les of Ss-Y6 (A) and N-acetylated Ss-Y6 (B) in positive ion mode ESI-MS.
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